Monday, May 09, 2022 10:57:20 AM
Good Morning again NSAV shareholders. As expected, persons unfriendly to NSAV are spreading falsehoods. The Colorado filing yesterday increased the Authorized Share for our common stock. That is all. Not a single share of common stock was issued. Therefore, no dilution, zero. https://twitter.com/nsavtech/status/1523623675936665600?s=21&t=_LpKeS8pG-aHGc03FDpYoA
If and when any new shares of common stock are issued, they will be restricted and locked up for 1 to 2 years. They will not increase or dilute the public float or market today, tomorrow, next week, next month, or in 6 months. Anyone who says otherwise is a liar. https://twitter.com/nsavtech/status/1523624680820666368?s=21&t=_LpKeS8pG-aHGc03FDpYoA
NSAV uses restricted Preferred B shares and in very rare cases, restricted common stock to make acquisitions, deals and partnerships. These deals are critical for the growth of NSAV and its crypto and blockchain ECOsystem and in the best interest of all NSAV shareholders. https://twitter.com/nsavtech/status/1523625541009510401?s=21&t=_LpKeS8pG-aHGc03FDpYoA
NSAV management believes that when we issue shares for acquisitions, deal or partnerships, we increase shareholders value, not decrease it, regardless of the day to day share price, which we are fully aware of. These deals will benefit all NSAV shareholders we believe. https://twitter.com/nsavtech/status/1523626298564018177?s=21&t=_LpKeS8pG-aHGc03FDpYoA
Again, NSAV's co-majority shareholder, TG Private Equity, Inc., just returned 500 million shares back to the company, in order to make them available for acquisitions and avoid or limit dilution. TG did that for all NSAV shareholders, not for their own benefit. https://twitter.com/nsavtech/status/1523627073952133120?s=21&t=_LpKeS8pG-aHGc03FDpYoA
To sum up, no dilution of NSAV shares took place yesterday. We urge all NSAV shareholders to look at the Colorado Secretary of State's website to confirm this. Not a single share was issued yesterday. Please don't listen to persons spreading falsehoods for their own personal gain https://twitter.com/nsavtech/status/1523628468675629056?s=21&t=_LpKeS8pG-aHGc03FDpYoA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM